Global miRNA Tools and Services Market Report 2022: Featuring GE, Thermo Fisher, Bio-Rad Laboratories, Promega & More

Company Logo
Company Logo

mirna-tools-and-services-market-share.jpg

mirna-tools-and-services-market-share.jpg
mirna-tools-and-services-market-share.jpg

Dublin, Dec. 02, 2022 (GLOBE NEWSWIRE) -- The "Global miRNA Tools and Services Market Size, Share & Industry Trends Analysis Report by Technology (qRT-PCR, Extraction Tools, NGS, Microarray, Functional Analysis Tools), End-user, Product & Services, Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

The Global miRNA Tools and Services Market size is expected to reach $939.8 million by 2028, rising at a market growth of 17.8% CAGR during the forecast period.

miRNA is a non-coding and small gene that is known to influence the expression of certain other genes. miRNAs or microRNAs control apoptosis, inflammation, immunological response, and development and differentiation. A miRNA tool kit provides researchers with practical tools to use when examining these phenomena at their most primitive level, enabling them to more quickly grasp how it functions than by trying to develop a custom test from the beginning.

The increase in cardiovascular disease and cancer incidences globally has boosted the usage of miRNA as a tool in screening and diagnosis processes. Additionally, the application of miRNA is expected to rise due to the usage of technological and bioinformatics-improved systems (such as NGS).

MicroRNAs, which are made up of 18-25 nucleotides, function as post-transcriptional negative regulators of gene expression. Through translational repression or the destruction of target mRNAs, miRNAs regulate the post-transcriptional regulation of genes. MiRNAs regulate a variety of biological activities including cell differentiation, development, proliferation, and death by altering the availability of mRNAs and protein synthesis.

Variations in miRNA-based expression profiles have been seen in a number of disorders, including cancer, osteoporosis, cardiac disease, and heart failure. These changes are linked to dysfunctional cellular processes. Numerous miRNAs affect tumor and oncogenes suppressor genes that are directly involved in the development of cancer.

Market Growth Factors
Rising technological advancements in the utilization of miRNA

In recent years, technological advancements in the crucial stages of miRNA expression profiling, validation, and target gene identification have provided manufacturers and researchers with the motivation to provide novel solutions.

For application in preclinical functional research and translational medicine, HTG Molecular Diagnostics Inc., for example, introduced a complete panel for miRNA expression analysis called the HTG EdgeSeq mouse miRNA whole transcriptome test. Due to their crucial roles in numerous biological processes, such as development, differentiation, cell proliferation, and death, miRNA expression profiling is of great interest.

Increasing number of clinical trials for chronic illnesses

MiRNA's pre-clinical and clinical research applications are being expanded by ongoing investigations and clinical trials. A growing number of studies point to the significant use of miRNAs as medications for medical therapy in practically all human health disorders, biomarkers for pathogenic diseases, or modulators of treatment resistance. As a result, one of the important reasons driving the growth of the miRNA is the expansion of clinical trials to assess the effectiveness of miRNA in the therapy of various chronic illnesses.

Market Restraining Factors

Inefficacy of miRNA in delivering results to the target

Similar to small interfering RNA medicines, microRNA-based therapies face difficulties with delivery, the possibility of off-target effects, and safety. The tissue-specific delivery of miRNA therapies is one of the main challenges. One miRNA's ability to target several genes is potentially a disadvantage because potential off-target effects could result in harmful outcomes. Another important consideration in the creation of miRNA therapies is the possibility that some biological activities of miRNAs could be partially redundant or cell-type dependent.

Scope of the Study
By Technology

  • qRT-PCR

  • Extraction Tools

  • NGS

  • Microarray

  • Functional Analysis Tools

  • Others

By End-user

  • Research & Academic Institutes

  • IVD, Pharma & Biotech Companies

  • CROs

By Product & Services

  • Research Tools

  • Services

By Geography

  • North America

    • US

    • Canada

    • Mexico

    • Rest of North America

  • Europe

    • Germany

    • UK

    • France

    • Russia

    • Spain

    • Italy

    • Rest of Europe

  • Asia Pacific

    • China

    • Japan

    • India

    • South Korea

    • Singapore

    • Malaysia

    • Rest of Asia Pacific

  • LAMEA

    • Brazil

    • Argentina

    • UAE

    • Saudi Arabia

    • South Africa

    • Nigeria

    • Rest of LAMEA

Key Market Players

  • General Electric (GE) Co.

  • Agilent Technologies, Inc.

  • Thermo Fisher Scientific, Inc.

  • Bio-Rad Laboratories, Inc.

  • Illumina, Inc.

  • Qiagen N.V.

  • New England BioLabs, Inc.

  • Promega Corporation

  • GeneCopoeia

  • Norgen Biotek Corp.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview

Chapter 3. Global miRNA Tools and Services Market by Technology

Chapter 4. Global miRNA Tools and Services Market by End-user

Chapter 5. Global miRNA Tools and Services Market by Product & Services

Chapter 6. Global miRNA Tools and Services Market by Region

Chapter 7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/sqza0f

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900